Genetic Polymorphisms in miRNAs and Susceptibility to Colorectal Cancer

Cell Biochemistry and Biophysics

Volumn 71, Issue 1, 2015, Pages 271-278

  Wu, Yu ^a,b   Hao, Xiaoxiong ^a   Feng, Zili ^a   Liu, Yunsheng ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b PLA   (China)

Author keywords

CRC; miRNA; SNPs

Indexed keywords

MICRORNA;

COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84920864440     PISSN: 10859195     EISSN: 15590283     Source Type: Journal    
DOI: 10.1007/s12013-014-0195-y     Document Type: Article

References (41)

1. Lewis, B. P., et al. (2003). Prediction of mammalian microRNA targets. Cell,115(7), 787–798.
2. Cai, Y., et al. (2009). A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics,7(4), 147–154.
3. Mocellin, S., Pasquali, S., & Pilati, P. (2009). Oncomirs: from tumor biology to molecularly targeted anticancer strategies. Mini Reviews in Medicinal Chemistry,9(1), 70–80.
4. Ambros, V. (2004). The functions of animal microRNAs. Nature,431(7006), 350–355.
5. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell,116(2), 281–297.
6. Johnnidis, J. B., et al. (2008). Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature,451(7182), 1125–1129.
7. Gong, J., et al. (2013). MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. Oncogene,32(25), 3071–3079.
8. Aumiller, V., & Forstemann, K. (2008). Roles of microRNAs beyond development–metabolism and neural plasticity. Biochimica et Biophysica Acta,1779(11), 692–696.
9. Sethupathy, P., & Collins, F. S. (2008). MicroRNA target site polymorphisms and human disease. Trends in Genetics,24(10), 489–497.
10. Chen, K., et al. (2008). Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis,29(7), 1306–1311.
11. Saunders, M. A., Liang, H., & Li, W. H. (2007). Human polymorphism at microRNAs and microRNA target sites. Proceedings of the National Academy of Sciences of the Unite States of America,104(9), 3300–3305.
12. Smith, R. A., et al. (2012). A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genomics & Proteomics,9(3), 115–118.
13. Hishida, A., et al. (2011). Combined effect of miR-146a rs2910164 G/C polymorphism and Toll-like receptor 4 +3725 G/C polymorphism on the risk of severe gastric atrophy in Japanese. Digestive Diseases and Sciences,56(4), 1131–1137.
14. Horikawa, Y., et al. (2008). Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clinical Cancer Research,14(23), 7956–7962.
15. Lung, R. W., et al. (2013). A single nucleotide polymorphism in microRNA-146a is associated with the risk for nasopharyngeal carcinoma. Molecular Carcinogenesis,52(S1), 28–38.
16. Bae, J. S., et al. (2012). Association study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseases. Digestive and liver disease,44(10), 849–854.
17. Garcia-Albeniz, X., & Chan, A. T. (2011). Aspirin for the prevention of colorectal cancer. Best Practice & Research Clinical Gastroenterology,25(4–5), 461–472.
18. Min, K. T., et al. (2012). Association of the miR-146aC > G, 149C > T, 196a2C > T, and 499A > G polymorphisms with colorectal cancer in the Korean population. Molecular Carcinogenesis,51(Suppl 1), E65–E73.
19. Chen, H., et al. (2012). A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese. Internal Medicine Journal,42(6), e115–e119.
20. Vinci, S., et al. (2013). Genetic and epigenetic factors in regulation of microRNA in colorectal cancers. Methods,59(1), 138–146.
21. Zhang, M., Study on the Associations of Lifestyle-related Factors, Genetic Variants in miRNA Encoding Regions and miRNA Binding Sites with Colorectal Cancer Risk. Zhejiang University: Zhejiang, 2012.
22. Chae, Y. S., et al. (2013). A miR-146a polymorphism (rs2910164) Predicts Risk of and Survival from Colorectal Cancer. Anticancer Research,33(8), 3233–3239.
23. Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine,21(11), 1539–1558.
24. DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials,7(3), 177–188.
25. Mantel, N., & Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute,22(4), 719–748.
26. Egger, M., et al. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ,315(7109), 629–634.
27. Zhan, J. F., et al. (2011). A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Archives of Medical Research,42(2), 144–148.
28. Zhu, L., et al. (2012). A functional polymorphism in miRNA-196a2 is associated with colorectal cancer risk in a Chinese population. DNA and Cell Biology,31(3), 350–354.
29. Hezova, R., et al. (2012). Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World Journal of Gastroenterology,18(22), 2827–2831.
30. Ma, L., et al. (2013). A genetic variant in miR-146a modifies colorectal cancer susceptibility in a Chinese population. Archives of Toxicology,87(5), 825–833.
31. Jang, M. J., et al. (2011). Prognostic significance of microRNA gene polymorphisms in patients with surgically resected colorectal cancer. Experimental and Therapeutic Medicine,2(6), 1127–1132.
32. Okayama, H., Schetter, A. J., & Harris, C. C. (2012). MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Digestive Diseases,30(Suppl 2), 9–15.
33. Tokarz, P., & Blasiak, J. (2012). The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Acta Biochimica Polonica,59(4), 467–474.
34. Berlin, J. A., & Kim, C. J. (2007). The use of meta-analysis in pharmacoepidemiology. In B. L. Strom (Ed.), pharmacoepidemiology (4th ed., pp. 681–707). New York: Wiley.
35. Wu, D., et al. (2013). The miR-146a rs2910164 G > C polymorphism and susceptibility to digestive cancer in Chinese. Asian Pacific Journal of Cancer Prevention,14(1), 399–403.
36. Xu, Y., et al. (2013). Different effects of three polymorphisms in MicroRNAs on cancer risk in Asian population: evidence from published literatures. PLoS ONE,8(6), e65123.
37. Zhang, Y. G., et al. (2013). Association of mir-499 and mir-149 polymorphisms with cancer risk in the Chinese population: evidence from published studies. Asian Pacific Journal of Cancer Prevention,14(4), 2337–2342.
38. Wang, F., et al. (2012). A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis. Molecular Biology Reports,39(1), 269–275.
39. Qiu, L. X., et al. (2011). miR-196a2 C allele is a low-penetrant risk factor for cancer development. Cytokine,56(3), 589–592.
40. Guo, J., et al. (2012). A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies. PLoS ONE,7(1), e30585.
41. He, B., et al. (2012). The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS ONE,7(11), e49032.